Associated Center:
Researcher(s) Keywords:
- vaccines
- Trypanosoma cruzi
- proteomics
- Prognosis
- Parasitology
- Microbiology
- Lipidomics
- Immunology
- Glycomics
- Glycobiology
- Clinical Trial
- Chemotherapy
- Chagas Disease
- Biomarkers
Featured Researcher(s):
Date: 17 June 2013 20:59

In a prestigious journal this year, researchers labeled Chagas disease as the new HIV/AIDS of the Americas. However, the epidemic may soon be facing its end, thanks to a recent development at The University of Texas at El Paso’s Border Biomedical Research Center (BBRC).
Igor C. Almeida, Ph.D., professor of biological sciences, has developed a fully protective vaccine against the parasite that causes the disease – Trypanosoma cruzi or T. cruzi.
Full story: [ Link to University Communications ]

